Izotropic Corporation | News
  • CSE: IZO
  • OTCQB: IZOZF
  • FSE: 1R3
Menu
1/30/2024
Izotropic Receives Response From U.S. FDA
VIEW
1/8/2024
Izotropic Provides Regulatory and Operational Updates
VIEW
12/22/2023
Izotropic Announces AGM Results- 2023
VIEW
11/1/2023
Izotropic Completes Pre-Submission Meeting With U.S. FDA
VIEW
9/27/2023
Izotropic Confirms FDA Pre-Submission Meeting Date
VIEW
9/20/2023
Izotropic Closes Non-Brokered Private Placement- September 2023
VIEW
9/13/2023
Izotropic Corporation Announces Non-Brokered Private Placement- September 2023
VIEW
9/6/2023
Izotropic Files Class II Pre-Submission with FDA & Releases Details On Predicate Devices
VIEW
6/27/2023
Izotropic Engages Market Awareness Consultant
VIEW
6/20/2023
Izotropic Modifies Market Approval Pathway & Strategy
VIEW
6/8/2023
Izotropic CEO Resigns
VIEW
5/15/2023
Izotropic Completes QSUB Meeting with FDA Regarding Clinical Study Acceleration
VIEW
4/27/2023
Izotropic Provides Business Update
VIEW
3/29/2023
Izotropic to Extend Period for Unsecured Loans
VIEW
2/23/2023
Izotropic’s Technical & Scientific Team Members Advocate for Commercialization of Breast CT Technology
VIEW
1/13/2023
Izotropic’s IzoView Breast CT Device To Be Featured On Advancements TV Show In USA
VIEW
1/12/2023
Izotropic Creates Compensation Committee and Adopts Charter
VIEW
1/9/2023
Izotropic Releases First Video of IzoView
VIEW
1/4/2023
Izotropic Reports Board Meeting Results
VIEW
12/28/2022
Izotropic Delays Announcements to 2023, Holds Board Meeting
VIEW
12/21/2022
Izotropic Announces 2022 AGM Results and Clarifies Restating of Financial Statements
VIEW
12/17/2022
Izotropic Corporation Files Amended and Restated Financial Statements For July 31, 2022
VIEW
12/1/2022
Izotropic Completes IzoView Development and Assembly, Prepares for Final Testing
VIEW
11/11/2022
Alexander Tokman Joins Izotropic Board of Directors
VIEW
11/10/2022
Izotropic Corporation Announces Closing Of Non-Brokered Private Placement- Nov 2022
VIEW
11/1/2022
Izotropic Grants Stock Options
VIEW
10/25/2022
Izotropic's IzoView is Weeks Away From Final Engineering & Showcasing to Investment and Scientific Communities
VIEW
8/11/2022
Izotropic Finalizes Engineering and Development Transition to The United States; Establishes Operations in Primary Target Market
VIEW
7/19/2022
Izotropic Engages Clinical Research Organization in Preparation for Clinical Study
VIEW
6/29/2022
Izotropic Reacts to Supply Chain Disruptions and Updates IzoView Engineering Timelines
VIEW
5/10/2022
Izotropic Unveils IzoView Commercial Prototype, Files New Patents
VIEW
4/19/2022
Izotropic Targets the Modern Investor and Engages Grit Capital
VIEW
4/18/2022
Izotropic Moves to Educate New Demographics On Breast CT, Engages New Consultants for Investor Relations & Awareness
VIEW
4/12/2022
Izotropic Announces Investor Conference Schedule
VIEW
4/4/2022
Izotropic Corporation Announces Closing of Non-Brokered Private Placement
VIEW
3/30/2022
Izotropic Corporation Announces Non-Brokered Private Placement
VIEW
3/14/2022
Breast CT Authority and Head of Clinical Trials Joins Izotropic
VIEW
3/7/2022
Izotropic Establishing Engineering and Development Facility in the USA
VIEW
11/29/2021
Izotropic Implements Quality Management System For Izoview Breast CT Device Manufacturing
VIEW
11/22/2021
Izotropic’s Breast CT Radiation Imaging Subsystem Powered On and Takes Initial Images
VIEW
11/5/2021
Izotropic Appoints Breast CT Expert As Head Of Imaging Technology
VIEW
10/26/2021
Izotropic Announces 2021 AGM Results
VIEW
10/13/2021
Izotropic Reaches Q3 Milestones and Provides Engineering Update
VIEW
9/21/2021
Izotropic Signs Agreement With Johns Hopkins University School of Medicine to Develop Deep Machine Learning Algorithms for IzoView Breast CT
VIEW
9/9/2021
Izotropic Nominated For Best New Radiology Device Award
VIEW
9/8/2021
Izotropic Receives Notice of Allowance For New 3D X-Ray Beam Filter Patent From USPTO
VIEW
9/8/2021
Izotropic Engages Consultants for Investor Relations and Dedicated Social Media and Communications Services
VIEW
6/30/2021
Izotropic Appoints Medical Device R&D Expert as Executive VP of Product Engineering
VIEW
6/3/2021
Izotropic Updates Timelines for Clinical Study and Fabrication of Initial Izoview Units
VIEW
5/28/2021
Izotropic Provides Corporate Update
VIEW
4/20/2021
Tomosynthesis Pioneer Joins Izotropic Scientific Advisory Board
VIEW
3/24/2021
Izotropic Accelerates Payor Engagement Activities with Excite International
VIEW
3/18/2021
Izotropic Launches Marketing Campaign
VIEW
3/15/2021
Izotropic Appoints Dr. John McGraw as Chief Executive Officer
VIEW
3/4/2021
Initial Insurance Billing Codes Issued for Dedicated Breast CT in the USA
VIEW
2/19/2021
Izotropic Launches New Website and Corporate Presentation
VIEW
2/9/2021
Izotropic Unveils “izoview” Branding For Breast CT Platform In Development And Files Trademark Applications
VIEW
2/3/2021
Izotropic Announces Upgrade to OTCQB Venture Market
VIEW
1/11/2021
Izotropic Grants Restricted and Performance Share Units
VIEW
1/7/2021
3D CT Imaging Expert Joins Izotropic Advisory
VIEW
1/5/2021
Izotropic Positioned to Execute in 2021
VIEW
12/31/2020
Izotropic Technology Founder Appointed Editor-In-Chief Of Medical Physics Journal
VIEW
12/15/2020
Izotropic Reports High Degree of Confidence After Pre-Submission Meeting With FDA
VIEW
12/9/2020
Izotropic Corporation Announces Closing of Non-Brokered Private Placement
VIEW
12/1/2020
Izotropic Cancels Options and Updates Amount of Broker Warrant Issued
VIEW
11/2/2020
Izotropic Engages Investor Relations and Market Awareness Consultants
VIEW
10/30/2020
Izotropic Corporation Announces Closing of Second Tranche of Non-Brokered Private Placement
VIEW
10/26/2020
Izotropic Unaware of Any Material Change
VIEW
10/20/2020
Izotropic Corporation Announces Non-Brokered Private Placement
VIEW
10/6/2020
Izotropic Announces 2020 AGM Results
VIEW
9/28/2020
Izotropic Announces Meeting Date With FDA
VIEW
9/15/2020
Mr. Alexander Tokman Joins Izotropic as Strategic Advisor
VIEW
8/31/2020
Izotropic Engages Marketsmart Communications
VIEW
8/28/2020
Izotropic Appoints Jaclyn Thast as Corporate Secretary
VIEW
8/18/2020
Izotropic Files Pre-Submission Application With U.S. FDA
VIEW
8/4/2020
Izotropic Unaware of Any Material Change
VIEW
7/10/2020
Izotropic Corporation Announces Adoption of Long Term Incentive Plan
VIEW
7/8/2020
Izotropic Engages Dr. Craig Abbey for Breast CT Reader Study Design
VIEW
7/6/2020
Izotropic Corporation Appoints Executive Vice President of Commercial Operations
VIEW
6/4/2020
Izotropic Engages Mr. James Berard for Investor Relation Services
VIEW
6/1/2020
Izotropic Corporation Announces Warrant Amendment
VIEW
5/27/2020
Izotropic Corporation Announces Issuance of Warrants Pursuant to January Warrant Incentive Program, Delayed Due to Covid-19
VIEW
5/25/2020
Izotropic Begins FDA Approval Process
VIEW
5/20/2020
FDA Consultant Joins Izotropic Advisory Board
VIEW
5/13/2020
Izotropic Engages Starfish Medical for Design and Development of Commercial Breast CT Model
VIEW
5/7/2020
Izotropic Announces Issuance of Patent to Use Breast CT for Robotic Guided Biopsy
VIEW
4/22/2020
Izotropic Announces Addition of George Burkett, M.Eng to Advisory Board
VIEW
4/15/2020
Izotropic Announces Issuance of Patent to Measure Breast Density With Breast CT Technology
VIEW
2/27/2020
Izotropic Provides Update on Globally Licensed Breast CT Technology
VIEW
2/26/2020
Izotropic Successfully Extends Exclusive Global License Agreement for Innovative Breast CT Technology Until 2027
VIEW
2/19/2020
Izotropic Receives Notice of Allowance for Measuring Breast Density From US Patent Office
VIEW
2/13/2020
Izotropic Corporation Announces Apppointment of Dr. John Mcgraw to Advisory Board
VIEW
2/11/2020
Izotropic Corporation Raises $1.23M From Warrant Exercise Program
VIEW
2/5/2020
Izotropic Corporation Receives Notice of Allowance From US Patent Office
VIEW
1/28/2020
Izotropic Corporation Announces Warrant Exercise Incentive Program
VIEW
1/23/2020
Izotropic Corporation Announces Cancellation and Issuance of Stock Options
VIEW
1/8/2020
What Could Google’s AI Capability Do with Real 3D Breast CT Images?
VIEW